Finance

Lists
TECX:NASDAQ
Tectonic Therapeutic Inc
$21.27
-0.19%
(-0.040) 1D
Oct 14, 10:14:42 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TECX...
Open
$21.22
High
$21.74
Low
$21.00
Mkt. cap
415.81M
Avg. vol.
225.68K
Volume
15.16K
52-wk high
$39.53
52-wk low
$15.52
EPS
-$4.56
Beta
1.24
Shares outstanding
19.55M
No. of employees
60
Open
$21.22
High
$21.74
Low
$21.00
Mkt. cap
415.81M
Avg. vol.
225.68K
Volume
15.16K
52-wk high
$39.53
52-wk low
$15.52
EPS
-$4.56
Beta
1.24
Shares outstanding
19.55M
No. of employees
60
News stories
From web sources and news partners
About Tectonic Therapeutic Inc
CEO-
Employees60
Founded2019
HeadquartersWatertown, Massachusetts, United States
SectorBiotechnology
Websitetectonictx.com
Analyst ratings
Based on 7 analysts giving stock ratings to TECX in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for TECX in the last 3 months.
Highest
Current $21.27
$93.00 (+337.24%)
Average
$71.14 (+234.46%)
Lowest
$26.00 (+22.24%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$76.00
+257.3%
10/14/2026
Unknown Analyst
UBS
Hold
Initiated
$26.00
+22.2%
10/11/2026
Alice Nettleton
UBS
Hold
Initiated
$26.00
+22.2%
10/12/2026
James Condulis
Stifel Nicolaus
Buy
Maintained
$75.00
+252.6%
10/01/2026
Benjamin Burnett
Wells Fargo
Buy
Reiterated
$93.00
+337.2%
09/29/2026
Gaurav Maini
LifeSci Capital
Buy
Maintained
$88.00
+313.7%
09/29/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
$80.00
+276.1%
09/01/2026
Uy Ear
Mizuho Securities
Buy
Reiterated
$85.00
+299.6%
08/27/2026
Danielle Brill
Truist Financial
Buy
Maintained
$60.00
+182.1%
08/10/2026
Martin Auster
Raymond James
Buy
Maintained
$81.00
+280.8%
05/26/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
16.93M
16.34M
20.87M
18.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.96M
5.18M
6.43M
6.17M
Operating expense
21.89M
21.52M
27.30M
24.22M
Total operating expenses
21.89M
21.52M
27.30M
24.22M
Operating income
-21.89M
-21.52M
-27.30M
-24.22M
Other non operating income
-31.00K
-8.00K
-113.00K
-5.00K
EBT including unusual items
-19.04M
-18.97M
-25.24M
-22.21M
EBT excluding unusual items
-19.04M
-18.97M
-25.24M
-22.21M
Income tax expense
-
254.00K
-
77.00K
Effective tax rate
-
-1.34%
-
-0.35%
Other operating expenses
-
-
-
-
Net income
-19.04M
-19.23M
-25.24M
-22.28M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2.90M
2.56M
2.18M
2.02M
Interest expense
-14.00K
-12.00K
-8.00K
-6.00K
Net interest expenses
2.89M
2.55M
2.17M
2.02M
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.55M
-21.18M
-27.00M
-23.93M
Gain or loss from assets sale
93.00K
-
23.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps